Antiatheroscleroic and antithrombotic 2-amino-6-phenyl-4H-pyran-

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5142315, 514277, 514311, 514397, 514406, 514824, 544121, A61K 3135, A61K 31535, A61K 31435, A61K 31415

Patent

active

053026136

ABSTRACT:
This invention relates to compounds of Formula I ##STR1## which are useful as antiatherosclerotic agents and inhibitors of cell proliferation for the treatment of proliferative diseases. In addition, various compounds of Formula I are useful inhibitors of platelet aggregation.

REFERENCES:
patent: 3029256 (1962-04-01), Cook
patent: 3419555 (1968-12-01), Jenkins
patent: 3468915 (1969-09-01), Tate
Capuano, L. et al., "Reactions of 2-Diazo-1,3-diketones with Enamines and Ketene-N,O-Acetals, II," Chem. Ber. 109:3497-3504 (1976).
Eaton, R. P., J. Chron. Dis., 31, pp. 131-135 (1978).
Haust, M. D., Adv. Exp. Med. Biol., 43, pp. 35-57 (1974).
Schurr, P. E., et al., Adv. Exp. Med. Biol., 67, pp. 215-229 (1975).
Day, C. E., et al., Laboratory Animal Science, 27, pp. 817-821 (1977).
Chem. Ber., 109(11), pp. 3497-3504 (1976).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antiatheroscleroic and antithrombotic 2-amino-6-phenyl-4H-pyran- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiatheroscleroic and antithrombotic 2-amino-6-phenyl-4H-pyran-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiatheroscleroic and antithrombotic 2-amino-6-phenyl-4H-pyran- will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2099035

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.